New OEM design wins and multi-year supply contract announcements - these drive long-term revenue visibility
Surgical procedure volume trends - particularly elective orthopedic and spinal surgeries which drive demand for powered surgical tools
Gross margin expansion or contraction - driven by product mix (higher-margin medical vs. dental), manufacturing efficiency, and raw material costs
FDA regulatory developments affecting surgical device approvals or quality system requirements
moderate - Medical device demand has defensive characteristics due to non-discretionary procedures, but Pro-Dex is exposed to elective surgery volumes which correlate with consumer confidence and employment. During economic downturns, patients may defer elective orthopedic and dental procedures, reducing OEM production schedules. However, aging demographics (65+ population growth) provide structural tailwind for joint replacement and spinal surgeries. Estimated 60% non-cyclical (trauma, emergency procedures) and 40% cyclical (elective surgeries, cosmetic dental work).
Rising interest rates have minimal direct impact on operations given low debt levels (0.28 D/E ratio) and strong balance sheet (4.03 current ratio). However, higher rates indirectly affect demand through two channels: (1) reduced consumer spending on elective medical and dental procedures as household budgets tighten, and (2) valuation multiple compression for small-cap growth stocks. The company's strong ROE (29.2%) and growth profile make it sensitive to discount rate changes in DCF-based valuations.
FDA regulatory changes or quality system enforcement actions - medical device component suppliers face stringent cGMP requirements and potential recalls that could disrupt production or damage customer relationships
Technology disruption from robotic surgery platforms or alternative surgical techniques that reduce demand for traditional powered surgical tools
Consolidation among medical device OEM customers - M&A activity could lead to vendor rationalization, pricing pressure, or loss of key accounts
growth - The 23.7% revenue growth, 322% net income growth, and 29.2% ROE attract growth-oriented investors seeking small-cap healthcare exposure. However, the $100M market cap, negative free cash flow, and illiquidity limit institutional participation. Typical shareholders include microcap specialists, healthcare-focused funds, and retail investors willing to accept volatility for growth potential. The stock's 31.1% three-month return followed by -9.8% six-month return demonstrates momentum characteristics.
Trend
+48.4% vs SMA 50 · +80.1% vs SMA 200
Momentum
Volume distribution is neutral or leaning toward distribution. No compelling squeeze setup based on current money flow data.
Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.
ANALYST ESTIMATES
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2023 | $47.0M $47.0M–$47.0M | — | $1.22 | — | — | Low1 |
FY2024 | $49.0M $49.0M–$49.0M | ▲ +4.3% | $0.50 | ▼ -59.0% | — | Low1 |
FY2025 | $67.0M $67.0M–$67.0M | ▲ +36.7% | $2.81 | ▲ +462.0% | — | Low1 |
INSTITUTIONAL OWNERSHIP
PDEX News
About
for over 40 years pro-dex has successfully collaborated with several of the world’s largest providers of medical and dental devices. wherever you are in your process, we can help you. whether your product is partially or fully-designed, we have the capabilities to deliver the services you’re in need of. our staff is experienced in providing engineering, precision machining and fabrication, electro-mechanical assembly, components, sub-assemblies, finished products, and flexible volumes - all with exceptional service. as we’ve experienced growth at pro-dex, we’ve recognized the need to expand our engineering services division. we can offer you powerful solutions including consulting, varying engineering services, and staffing. we’re here to connect you with engineering support for the mechanical, electrical, and manufacturing needs of your company. while we may have built our business around the design and manufacturing for medical oem’s, we have since found increased success working wit
| Symbol | Price | Day % | Mkt Cap↓ | P/E | Rev Grw | Margin | ELO |
|---|---|---|---|---|---|---|---|
PDEX◀ | $59.27 | +1.06% | $189M | 15.8 | +2367.8% | 1348.2% | 1500 |
| $66.13 | -5.07% | $13.0B | — | +12626.1% | -14525.8% | 1500 | |
| $94.92 | -3.79% | $12.6B | — | +3288.2% | -4239.0% | 1500 | |
| $523.69 | -3.00% | $12.1B | — | +43205.3% | -3008.0% | 1500 | |
| $227.72 | -1.96% | $11.7B | — | +6554.5% | -2868.8% | 1500 | |
| $57.90 | -0.86% | $11.2B | 50.3 | +1459.3% | 147.7% | 1500 | |
| $76.67 | -3.79% | $10.8B | — | +2325815.3% | -19.7% | 1500 | |
| Sector avg | — | -2.49% | — | 33.1 | +342188.1% | -3309.3% | 1500 |